- Motif Bio has appointed Westwicke Partners as investor relations adviser in the US.

Motif chief executive Graham Lumsden said: "We look forward to building a relationship with the Westwicke team and to leveraging their experience as we continue to move our clinical development programs forward."

At 1:28pm: [LON:MTFB] Motif Bio Plc Ord 1p share price was +3.5p at 58p

Story provided by